The anticancer agent 3-bromopyruvate: a simple but powerful molecule taken from the lab to the bedside
Published 2016 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
The anticancer agent 3-bromopyruvate: a simple but powerful molecule taken from the lab to the bedside
Authors
Keywords
3-bromopyruvate, Monocarboxylate transporter, Cancer metabolism, Tumor microenvironment, Cancer therapy, Clinical studies
Journal
JOURNAL OF BIOENERGETICS AND BIOMEMBRANES
Volume 48, Issue 4, Pages 349-362
Publisher
Springer Nature
Online
2016-07-25
DOI
10.1007/s10863-016-9670-z
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- 3-Bromopyruvate and sodium citrate induce apoptosis in human gastric cancer cell line MGC-803 by inhibiting glycolysis and promoting mitochondria-regulated apoptosis pathway
- (2016) Xingyu Guo et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- The cytotoxicity of 3-bromopyruvate in breast cancer cells depends on extracellular pH
- (2015) João Azevedo-Silva et al. BIOCHEMICAL JOURNAL
- Organization of Enzyme Concentration across the Metabolic Network in Cancer Cells
- (2015) Neel S. Madhukar et al. PLoS One
- The energy blocker inside the power house: mitochondria targeted delivery of 3-bromopyruvate
- (2015) Sean Marrache et al. Chemical Science
- Primary clear cell renal carcinoma cells display minimal mitochondrial respiratory capacity resulting in pronounced sensitivity to glycolytic inhibition by 3-Bromopyruvate
- (2015) H Nilsson et al. Cell Death & Disease
- The energy blockers bromopyruvate and lonidamine lead GL15 glioblastoma cells to death by different p53-dependent routes
- (2015) Magdalena Davidescu et al. Scientific Reports
- Inhibition of glucose turnover by 3-bromopyruvate counteracts pancreatic cancer stem cell features and sensitizes cells to gemcitabine
- (2015) Orkhan Isayev et al. Oncotarget
- 3-Bromopyruvic Acid, A Hexokinase II Inhibitor, is an Effective Antitumor Agent on the Hepatoma Cells : in vitro and in vivo Findings
- (2014) Lei Gong et al. Anti-Cancer Agents in Medicinal Chemistry
- 3-Bromopyruvate induces apoptosis in breast cancer cells by downregulating Mcl-1 through the PI3K/Akt signaling pathway
- (2014) Zhe Liu et al. ANTI-CANCER DRUGS
- Killing multiple myeloma cells with the small molecule 3-bromopyruvate
- (2014) Grażyna Majkowska-Skrobek et al. ANTI-CANCER DRUGS
- The antitumor agent 3-bromopyruvate has a short half-life at physiological conditions
- (2014) Matthew Glick et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- Mitochondrial dysfunction in cancer chemoresistance
- (2014) Nicoletta Guaragnella et al. BIOCHEMICAL PHARMACOLOGY
- Metabolic Vulnerabilities in Endometrial Cancer
- (2014) F. L. Byrne et al. CANCER RESEARCH
- Systemic Delivery of Microencapsulated 3-Bromopyruvate for the Therapy of Pancreatic Cancer
- (2014) J. Chapiro et al. CLINICAL CANCER RESEARCH
- Mitochondria: 3-bromopyruvate vs. mitochondria? A small molecule that attacks tumors by targeting their bioenergetic diversity
- (2014) Antonio Galina INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY
- The energy blockers 3-bromopyruvate and lonidamine: effects on bioenergetics of brain mitochondria
- (2014) Lara Macchioni et al. JOURNAL OF BIOENERGETICS AND BIOMEMBRANES
- 3-bromopyruvate inhibits glycolysis, depletes cellular glutathione, and compromises the viability of cultured primary rat astrocytes
- (2014) Eric Ehrke et al. JOURNAL OF NEUROSCIENCE RESEARCH
- Glycolysis inhibition and its effect in doxorubicin resistance in neuroblastoma
- (2014) Jonathan F. Bean et al. JOURNAL OF PEDIATRIC SURGERY
- Local delivery of cancer-cell glycolytic inhibitors in high-grade glioma
- (2014) Robert T. Wicks et al. NEURO-ONCOLOGY
- The Reversal Effects of 3-Bromopyruvate on Multidrug Resistance In Vitro and In Vivo Derived from Human Breast MCF-7/ADR Cells
- (2014) Long Wu et al. PLoS One
- The Scarlet Letter of Alkylation: A Mini Review of Selective Alkylating Agents
- (2014) Bryan T. Oronsky et al. Translational Oncology
- Safety and outcome of treatment of metastatic melanoma using 3-bromopyruvate: a concise literature review and case study
- (2014) Salah Mohamed El Sayed et al. Chinese Journal of Cancer
- 3-Bromopyruvate: A novel antifungal agent against the human pathogen Cryptococcus neoformans
- (2013) Mariusz Dyląg et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- Enhanced cytotoxicity to cancer cells by mitochondria-targeting MWCNTs containing platinum(IV) prodrug of cisplatin
- (2013) Sia Lee Yoong et al. BIOMATERIALS
- How does the metabolism of tumour cells differ from that of normal cells
- (2013) Nívea Dias Amoêdo et al. BIOSCIENCE REPORTS
- Effect of 3-bromopyruvic acid on human erythrocyte antioxidant defense system
- (2013) Izabela Sadowska-Bartosz et al. CELL BIOLOGY INTERNATIONAL
- Antiglycolytic Therapy Combined with an Image-guided Minimally Invasive Delivery Strategy for the Treatment of Breast Cancer
- (2013) Manon Buijs et al. JOURNAL OF VASCULAR AND INTERVENTIONAL RADIOLOGY
- Combination studies of platinum(ii)-based metallointercalators with buthionine-S,R-sulfoximine, 3-bromopyruvate, cisplatin or carboplatin
- (2013) K. Benjamin Garbutcheon-Singh et al. Metallomics
- Ultrasound-guided direct delivery of 3-bromopyruvate blocks tumor progression in an orthotopic mouse model of human pancreatic cancer
- (2013) Shinichi Ota et al. Targeted Oncology
- Expression of glucose transporters in cancers
- (2012) Leszek Szablewski BIOCHIMICA ET BIOPHYSICA ACTA-REVIEWS ON CANCER
- Repeated cisplatin treatment can lead to a multiresistant tumor cell population with stem cell features and sensitivity to 3-bromopyruvate
- (2012) My Wintzell et al. CANCER BIOLOGY & THERAPY
- Aerosolized 3-Bromopyruvate Inhibits Lung Tumorigenesis without Causing Liver Toxicity
- (2012) Q. Zhang et al. Cancer Prevention Research
- Glutamine Deprivation Enhances Antitumor Activity of 3-Bromopyruvate through the Stabilization of Monocarboxylate Transporter-1
- (2012) S. Cardaci et al. CANCER RESEARCH
- Novel insight into the role of GAPDH playing in tumor
- (2012) Chunmei Guo et al. Clinical & Translational Oncology
- D-Amino acid oxidase-induced oxidative stress, 3-bromopyruvate and citrate inhibit angiogenesis, exhibiting potent anticancer effects
- (2012) S. M. El Sayed et al. JOURNAL OF BIOENERGETICS AND BIOMEMBRANES
- Butyrate activates the monocarboxylate transporter MCT4 expression in breast cancer cells and enhances the antitumor activity of 3-bromopyruvate
- (2012) Odília Queirós et al. JOURNAL OF BIOENERGETICS AND BIOMEMBRANES
- Flow cytometric evaluation of the effects of 3-bromopyruvate (3BP) and dichloracetate (DCA) on THP-1 cells: a multiparameter analysis
- (2012) Harrie A. Verhoeven et al. JOURNAL OF BIOENERGETICS AND BIOMEMBRANES
- Bromopyruvate mediates autophagy and cardiolipin degradation to monolyso-cardiolipin in GL15 glioblastoma cells
- (2012) Magdalena Davidescu et al. JOURNAL OF BIOENERGETICS AND BIOMEMBRANES
- Effect of the antitumoral alkylating agent 3-bromopyruvate on mitochondrial respiration: role of mitochondrially bound hexokinase
- (2012) Clara Rodrigues-Ferreira et al. JOURNAL OF BIOENERGETICS AND BIOMEMBRANES
- Experimental results using 3-bromopyruvate in mesothelioma: in vitro and in vivo studies
- (2012) Icard Philippe et al. JOURNAL OF BIOENERGETICS AND BIOMEMBRANES
- Mitochondria in relation to cancer metastasis: introduction to a mini-review series
- (2012) Peter L. Pedersen JOURNAL OF BIOENERGETICS AND BIOMEMBRANES
- Over-expression of GAPDH in human colorectal carcinoma as a preferred target of 3-Bromopyruvate Propyl Ester
- (2012) Zhenjie Tang et al. JOURNAL OF BIOENERGETICS AND BIOMEMBRANES
- Enhancement of hexokinase II inhibitor-induced apoptosis in hepatocellular carcinoma cells via augmenting ER stress and anti-angiogenesis by protein disulfide isomerase inhibition
- (2012) Su Jong Yu et al. JOURNAL OF BIOENERGETICS AND BIOMEMBRANES
- Up-regulation of hexokinaseII in myeloma cells: targeting myeloma cells with 3-bromopyruvate
- (2012) Ayako Nakano et al. JOURNAL OF BIOENERGETICS AND BIOMEMBRANES
- Role of monocarboxylate transporters in human cancers: state of the art
- (2012) Céline Pinheiro et al. JOURNAL OF BIOENERGETICS AND BIOMEMBRANES
- A translational study “case report” on the small molecule “energy blocker” 3-bromopyruvate (3BP) as a potent anticancer agent: from bench side to bedside
- (2012) Y. H. Ko et al. JOURNAL OF BIOENERGETICS AND BIOMEMBRANES
- 3-Bromopyruvate antagonizes effects of lactate and pyruvate, synergizes with citrate and exerts novel anti-glioma effects
- (2012) S. M. El Sayed et al. JOURNAL OF BIOENERGETICS AND BIOMEMBRANES
- 3-bromopyruvate (3BP) a fast acting, promising, powerful, specific, and effective “small molecule” anti-cancer agent taken from labside to bedside: introduction to a special issue
- (2012) Peter L. Pedersen JOURNAL OF BIOENERGETICS AND BIOMEMBRANES
- 3-bromopyruvate: Targets and outcomes
- (2012) Maria C. Shoshan JOURNAL OF BIOENERGETICS AND BIOMEMBRANES
- Glycolysis inhibitors as a potential therapeutic option to treat aggressive neuroblastoma expressing GLUT1
- (2012) Kohei Matsushita et al. JOURNAL OF PEDIATRIC SURGERY
- EPR oxygen imaging and hyperpolarized13C MRI of pyruvate metabolism as noninvasive biomarkers of tumor treatment response to a glycolysis inhibitor 3-bromopyruvate
- (2012) Shingo Matsumoto et al. MAGNETIC RESONANCE IN MEDICINE
- The Warburg Effect Dictates the Mechanism of Butyrate-Mediated Histone Acetylation and Cell Proliferation
- (2012) Dallas R. Donohoe et al. MOLECULAR CELL
- MCT1-mediated transport of a toxic molecule is an effective strategy for targeting glycolytic tumors
- (2012) Kivanç Birsoy et al. NATURE GENETICS
- Separate and concurrent use of 2-deoxy-D-glucose and 3-bromopyruvate in pancreatic cancer cells
- (2012) HUIJIE XIAO et al. ONCOLOGY REPORTS
- Human Hepatocellular Carcinoma in a Mouse Model: Assessment of Tumor Response to Percutaneous Ablation by Using Glyceraldehyde-3-Phosphate Dehydrogenase Antagonists
- (2012) Shanmugasundaram Ganapathy-Kanniappan et al. RADIOLOGY
- Identification and Functional Expression of the Mitochondrial Pyruvate Carrier
- (2012) S. Herzig et al. SCIENCE
- A Mitochondrial Pyruvate Carrier Required for Pyruvate Uptake in Yeast, Drosophila, and Humans
- (2012) D. K. Bricker et al. SCIENCE
- Inhibition of hypoxia-inducible carbonic anhydrase-IX enhances hexokinase II inhibitor-induced hepatocellular carcinoma cell apoptosis
- (2011) Su-jong Yu et al. ACTA PHARMACOLOGICA SINICA
- Up-regulation of glyceraldehyde-3-phosphate dehydrogenase gene expression by HIF-1 activity depending on Sp1 in hypoxic breast cancer cells
- (2011) Yasuki Higashimura et al. ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS
- D-amino acid oxidase gene therapy sensitizes glioma cells to the antiglycolytic effect of 3-bromopyruvate
- (2011) S M El Sayed et al. CANCER GENE THERAPY
- Intracellular ATP Levels Are a Pivotal Determinant of Chemoresistance in Colon Cancer Cells
- (2011) Y. Zhou et al. CANCER RESEARCH
- Mitochondrial dysfunction and effect of antiglycolytic bromopyruvic acid in GL15 glioblastoma cells
- (2011) Lara Macchioni et al. JOURNAL OF BIOENERGETICS AND BIOMEMBRANES
- The bioenergetic signature of isogenic colon cancer cells predicts the cell death response to treatment with 3-bromopyruvate, iodoacetate or 5-fluorouracil
- (2011) María Sánchez-Aragó et al. Journal of Translational Medicine
- Glycolysis Inhibition Inactivates ABC Transporters to Restore Drug Sensitivity in Malignant Cells
- (2011) Ayako Nakano et al. PLoS One
- Glyoxalase in tumourigenesis and multidrug resistance
- (2011) Paul J. Thornalley et al. SEMINARS IN CELL & DEVELOPMENTAL BIOLOGY
- Systemic administration of 3-bromopyruvate in treating disseminated aggressive lymphoma
- (2011) Niklaus G. Schaefer et al. Translational Research
- 3-Bromopyruvate induces necrotic cell death in sensitive melanoma cell lines
- (2010) J.-Z. Qin et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- A note from history: Landmarks in history of cancer, part 1
- (2010) Steven I. Hajdu CANCER
- The diverse functions of GAPDH: Views from different subcellular compartments
- (2010) Carlos Tristan et al. CELLULAR SIGNALLING
- 3-Bromopyruvate: A New Targeted Antiglycolytic Agent and a Promise for Cancer Therapy
- (2010) S. Ganapathy-Kanniappan et al. CURRENT PHARMACEUTICAL BIOTECHNOLOGY
- Mitochondrial and plasma membrane lactate transporter and lactate dehydrogenase isoform expression in breast cancer cell lines
- (2010) Rajaa Hussien et al. PHYSIOLOGICAL GENOMICS
- Metabolic Modulation of Glioblastoma with Dichloroacetate
- (2010) E. D. Michelakis et al. Science Translational Medicine
- Role of mitochondria-associated hexokinase II in cancer cell death induced by 3-bromopyruvate
- (2009) Zhao Chen et al. BIOCHIMICA ET BIOPHYSICA ACTA-BIOENERGETICS
- Transport by SLC5A8 with subsequent inhibition of histone deacetylase 1 (HDAC1) and HDAC3 underlies the antitumor activity of 3-bromopyruvate
- (2009) Muthusamy Thangaraju et al. CANCER
- Targets of 3-Bromopyruvate, A New, Energy Depleting, Anticancer Agent
- (2009) P. Dell'Antone Medicinal Chemistry
- Glucose Deprivation Contributes to the Development of KRAS Pathway Mutations in Tumor Cells
- (2009) J. Yun et al. SCIENCE
- Understanding the Warburg Effect: The Metabolic Requirements of Cell Proliferation
- (2009) M. G. Vander Heiden et al. SCIENCE
- Sodium-coupled Monocarboxylate Transporters in Normal Tissues and in Cancer
- (2008) Vadivel Ganapathy et al. AAPS Journal
- Inhibition of energy-producing pathways of HepG2 cells by 3-bromopyruvate1
- (2008) Ana Paula Pereira Da Silva et al. BIOCHEMICAL JOURNAL
- Inhibition of glycolysis modulates prednisolone resistance in acute lymphoblastic leukemia cells
- (2008) E. Hulleman et al. BLOOD
- Non-invasive MRI tumor imaging and synergistic anticancer effect of HSP90 inhibitor and glycolysis inhibitor in RIP1-Tag2 transgenic pancreatic tumor model
- (2008) Xianhua Cao et al. CANCER CHEMOTHERAPY AND PHARMACOLOGY
- Development of a new orthotopic animal model of metastatic liver cancer in the rabbit VX2 model: effect on metastases after partial hepatectomy, intra-arterial treatment with 3-bromopyruvate and chemoembolization
- (2008) Josephina A. Vossen et al. CLINICAL & EXPERIMENTAL METASTASIS
- Specificity of the anti-glycolytic activity of 3-bromopyruvate confirmed by FDG uptake in a rat model of breast cancer
- (2008) Manon Buijs et al. INVESTIGATIONAL NEW DRUGS
- Role of reactive oxygen species-mediated mitochondrial dysregulation in 3-bromopyruvate induced cell death in hepatoma cells
- (2008) Ji Su Kim et al. JOURNAL OF BIOENERGETICS AND BIOMEMBRANES
- Targeting lactate-fueled respiration selectively kills hypoxic tumor cells in mice
- (2008) Pierre Sonveaux et al. JOURNAL OF CLINICAL INVESTIGATION
- 3-Bromopyruvate as inhibitor of tumour cell energy metabolism and chemopotentiator of platinum drugs
- (2008) Linda Strandberg Ihrlund et al. Molecular Oncology
- Hexokinase-2 bound to mitochondria: Cancer's stygian link to the “Warburg effect” and a pivotal target for effective therapy
- (2008) Saroj P. Mathupala et al. SEMINARS IN CANCER BIOLOGY
Become a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get StartedAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started